09/29/2026
We’re excited to be among the first practices to offer Epioxa™ (riboflavin 5’-
phosphate ophthalmic solution). The first FDA-approved, epithelium-on, oxygen -
enriched corneal cross-linking treatment for keratoconus. A new interventional approach designed for improved comfort and recovery. Grateful for the collaboration and dedication to be able to offer this innovative
therapy for patients. Visit epioxa.com/important-safety-information for Important Safety Information.
#
Glaukos LivingwithKC InterventionalKC